ENDRA Life Sciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$10,060,250 over the previous period. Total operating expenses were $10,520,735.

Profit Margin

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Profit margin
2014 559.35K -2.18M -389.89%
2015 1.41M -2.27M -161.64%
2016 515.58K -2.77M -538.3%
2017 351.62K -5.37M -1529.19%
2018 6.17K -9.79M -158669.6%
2019 0 -15.55M
2020 0 -11.96M
2021 0 -11.18M
2022 0 -13.20M
2023 0 -10.06M

NDRA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000006.17K351.62K515.58K1.41M559.35K
Cost of revenue
275.45K234.25K224.41K165.24K115.01K0172.78K235.87K666.23K259.14K
Gross profit
-275.45K-234.25K-224.41K-165.24K-115.01K6.17K178.84K279.70K743.83K300.21K
Operating exp.
Research and development
5.00M6.55M5.48M5.91M6.57M4.72M1.93M495.37K1.03M873.16K
Selling and marketing
820.55K1.42M1.07M581.89K412.43K262.64K122.60K34.13K50.63K56.29K
Total operating expenses
10.52M13.15M11.49M11.50M10.84M8.73M4.80M2.07M2.31M1.82M
Operating income
-10.52M-13.15M-11.49M-11.50M-10.84M-9.01M-4.62M-1.79M-1.56M-1.52M
Other income (expenses), net
460.48K-21.53K267.05K-223.58K-2.46M-1.06M-750.90K-983.61K-710.63K-654.69K
Income before tax
-10.06M-13.17M-11.23M-11.72M-13.30M-9.79M-5.37M-2.77M-2.27M-2.18M
Income tax expense
021.53K-41.54K241.26K2.24M-777.25K750.90K983.61K710.63K654.69K
Net income
-10.06M-13.20M-11.18M-11.96M-15.55M-9.79M-5.37M-2.77M-2.27M-2.18M
Earnings per share
Basic EPS
-1.11-4.57-5.47-12.47-41.48-43.49-39.01-14.21-11.67-11.16
Diluted EPS
-1.11-4.57-5.47-12.47-41.48-43.49-39.01-14.21-11.67-11.16
Data sourceData sourceData sourceData sourceData sourceData sourceData source